Astha Tejpal1, Eugenia Gianos1,2, Jane Cerise3, Jamie S Hirsch2,3,4,5, Stacey Rosen2,6, Nina Kohn3, Martin Lesser2,3, Catherine Weinberg1,2, David Majure2,6, Sanjaya K Satapathy2,7, David Bernstein2,7, Matthew A Barish2,8, Alex C Spyropoulos2,3,9, Rachel-Maria Brown1,2. 1. Division of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York, USA. 2. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA. 3. Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA. 4. Department of Nephrology and Hypertension, North Shore University Hospital, Manhasset, New York, USA. 5. Department of Information Services, Northwell Health, New Hyde Park, New York, USA. 6. Division of Cardiology, North Shore University Medical Center, Manhasset, New York, USA. 7. Division of Hepatology, North Shore University Medical Center, Manhasset, New York, USA. 8. Department of Radiology, North Shore University Hospital, Northwell Health, Manhasset, New York, USA. 9. Department of Internal Medicine, North Shore University Medical Center, Manhasset, New York, USA.
Abstract
Background: Smaller studies suggest lower morbidity and mortality associated with coronavirus disease 2019 (COVID-19) in women. Our aim is to assess the impact of female sex on outcomes in a large cohort of patients hospitalized with COVID-19. Materials and Methods: This is a retrospective observational cohort study of 10,630 adult patients hospitalized with a confirmed COVID-19 polymerase chain reaction between March 1, 2020 and April 27, 2020, with follow-up conducted through June 4, 2020. Logistic regression was used to examine the relationship between sex and the primary outcomes, including length of stay, admission to intensive care unit (ICU), need for mechanical ventilation, pressor requirement, and all-cause mortality as well as major adverse events and in-hospital COVID-19 treatments. Results: In the multivariable analysis, women had 27% lower odds of in-hospital mortality (odds ratio [OR] = 0.73, 95% confidence interval [CI] 0.66-0.81; p < 0.001), 24% lower odds of ICU admission (OR = 0.76, 95% CI 0.69-0.84; p < 0.001), 26% lower odds of mechanical ventilation (OR = 0.74, 95% CI 0.66-0.82; p < 0.001), and 25% lower odds of vasopressor requirement (OR = 0.75, 95% CI 0.67-0.84; p < 0.001). Women had 34% less odds of having acute cardiac injury (OR = 0.66, 95% CI 0.59-0.74; p < 0.001; n = 7,289), 16% less odds of acute kidney injury (OR = 0.84, 95% CI 0.76-0.92; p < 0.001; n = 9,840), and 27% less odds of venous thromboembolism (OR = 0.73, 95% CI 0.56-0.96; p < 0.02; c-statistic 0.85, n = 9,407). Conclusions: Female sex is associated with lower odds of in-hospital outcomes, major adverse events, and all-cause mortality. There may be protective mechanisms inherent to female sex, which explain differences in COVID-19 outcomes.
Background: Smaller studies suggest lower morbidity and mortality associated with coronavirus disease 2019 (COVID-19) in women. Our aim is to assess the impact of female sex on outcomes in a large cohort of patients hospitalized with COVID-19. Materials and Methods: This is a retrospective observational cohort study of 10,630 adult patients hospitalized with a confirmed COVID-19 polymerase chain reaction between March 1, 2020 and April 27, 2020, with follow-up conducted through June 4, 2020. Logistic regression was used to examine the relationship between sex and the primary outcomes, including length of stay, admission to intensive care unit (ICU), need for mechanical ventilation, pressor requirement, and all-cause mortality as well as major adverse events and in-hospital COVID-19 treatments. Results: In the multivariable analysis, women had 27% lower odds of in-hospital mortality (odds ratio [OR] = 0.73, 95% confidence interval [CI] 0.66-0.81; p < 0.001), 24% lower odds of ICU admission (OR = 0.76, 95% CI 0.69-0.84; p < 0.001), 26% lower odds of mechanical ventilation (OR = 0.74, 95% CI 0.66-0.82; p < 0.001), and 25% lower odds of vasopressor requirement (OR = 0.75, 95% CI 0.67-0.84; p < 0.001). Women had 34% less odds of having acute cardiac injury (OR = 0.66, 95% CI 0.59-0.74; p < 0.001; n = 7,289), 16% less odds of acute kidney injury (OR = 0.84, 95% CI 0.76-0.92; p < 0.001; n = 9,840), and 27% less odds of venous thromboembolism (OR = 0.73, 95% CI 0.56-0.96; p < 0.02; c-statistic 0.85, n = 9,407). Conclusions: Female sex is associated with lower odds of in-hospital outcomes, major adverse events, and all-cause mortality. There may be protective mechanisms inherent to female sex, which explain differences in COVID-19 outcomes.
Entities:
Keywords:
COVID-19; gender; hospital outcomes; intensive care; mortality; sex
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Laurence Needleman; John J Cronan; Michael P Lilly; Geno J Merli; Srikar Adhikari; Barbara S Hertzberg; M Robert DeJong; Michael B Streiff; Mark H Meissner Journal: Circulation Date: 2018-04-03 Impact factor: 29.690
Authors: Daniel Mølager Christensen; Jarl Emanuel Strange; Gunnar Gislason; Christian Torp-Pedersen; Thomas Gerds; Emil Fosbøl; Matthew Phelps Journal: J Gen Intern Med Date: 2020-06-24 Impact factor: 5.128
Authors: Mohamad Alkhouli; Aravinda Nanjundappa; Frank Annie; Mark C Bates; Deepak L Bhatt Journal: Mayo Clin Proc Date: 2020-05-29 Impact factor: 7.616
Authors: Takehiro Takahashi; Mallory K Ellingson; Patrick Wong; Benjamin Israelow; Carolina Lucas; Jon Klein; Julio Silva; Tianyang Mao; Ji Eun Oh; Maria Tokuyama; Peiwen Lu; Arvind Venkataraman; Annsea Park; Feimei Liu; Amit Meir; Jonathan Sun; Eric Y Wang; Arnau Casanovas-Massana; Anne L Wyllie; Chantal B F Vogels; Rebecca Earnest; Sarah Lapidus; Isabel M Ott; Adam J Moore; Albert Shaw; John B Fournier; Camila D Odio; Shelli Farhadian; Charles Dela Cruz; Nathan D Grubaugh; Wade L Schulz; Aaron M Ring; Albert I Ko; Saad B Omer; Akiko Iwasaki Journal: Nature Date: 2020-08-26 Impact factor: 49.962
Authors: Caitlin E Martin; Bhushan Thakkar; DaShaunda D H Taylor; Derek A Chapman Journal: J Womens Health (Larchmt) Date: 2022-02-15 Impact factor: 3.017
Authors: Alexandra Jablonka; Christian Dopfer; Christine Happle; Andree Shalabi; Martin Wetzke; Eva Hummers; Tim Friede; Stephanie Heinemann; Nele Hillermann; Anne Simmenroth; Frank Müller Journal: NPJ Prim Care Respir Med Date: 2021-12-21 Impact factor: 2.871
Authors: Nathália Mariana Santos Sansone; Letícia Rogini Pereira; Matheus Negri Boschiero; Felipe Eduardo Valencise; Andréa Melo Alexandre Fraga; Fernando Augusto Lima Marson Journal: Int J Environ Res Public Health Date: 2022-07-22 Impact factor: 4.614
Authors: Tjede Funk; Francesco Innocenti; Joana Gomes Dias; Lina Nerlander; Tanya Melillo; Charmaine Gauci; Jackie M Melillo; Patrik Lenz; Helena Sebestova; Pavel Slezak; Iva Vlckova; Jacob Dag Berild; Camilla Mauroy; Elina Seppälä; Ragnhild Tønnessen; Anne Vergison; Joël Mossong; Silvana Masi; Laetitia Huiart; Gillian Cullen; Niamh Murphy; Lois O'Connor; Joan O'Donnell; Piers Mook; Richard G Pebody; Nick Bundle Journal: Euro Surveill Date: 2022-09